CY1110369T1 - Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη - Google Patents

Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη

Info

Publication number
CY1110369T1
CY1110369T1 CY20081101017T CY081101017T CY1110369T1 CY 1110369 T1 CY1110369 T1 CY 1110369T1 CY 20081101017 T CY20081101017 T CY 20081101017T CY 081101017 T CY081101017 T CY 081101017T CY 1110369 T1 CY1110369 T1 CY 1110369T1
Authority
CY
Cyprus
Prior art keywords
roflumilast
formoterol
cooperative combination
new cooperative
new
Prior art date
Application number
CY20081101017T
Other languages
English (en)
Inventor
Rolf Beume
Daniela Bundschuh
Norbert Kolassa
Degenhard Marx
Christian Weimar
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of CY1110369T1 publication Critical patent/CY1110369T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η εφεύρεση αφορά συνδυασμένη χορήγηση ροφλουμιλάστης και φορμοτερόλης δια την θεραπευτική αγωγή παθήσεων του αναπνευστικού συστήματος.
CY20081101017T 2002-11-27 2008-09-17 Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη CY1110369T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02026505 2002-11-27
EP03767663A EP1567139B1 (en) 2002-11-27 2003-11-26 New synergistic combination comprising roflumilast and formoterol

Publications (1)

Publication Number Publication Date
CY1110369T1 true CY1110369T1 (el) 2015-04-29

Family

ID=32338002

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101017T CY1110369T1 (el) 2002-11-27 2008-09-17 Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη

Country Status (32)

Country Link
US (1) US20060142308A1 (el)
EP (1) EP1567139B1 (el)
JP (1) JP2006508994A (el)
KR (1) KR101071798B1 (el)
CN (1) CN100346777C (el)
AT (1) ATE399543T1 (el)
AU (1) AU2003292120B2 (el)
BR (1) BR0316451A (el)
CA (1) CA2506962C (el)
CO (1) CO5690570A2 (el)
CY (1) CY1110369T1 (el)
DE (1) DE60321953D1 (el)
DK (1) DK1567139T3 (el)
EA (1) EA009935B1 (el)
ES (1) ES2309357T3 (el)
HK (1) HK1081861A1 (el)
HR (1) HRP20050579B1 (el)
IL (1) IL168308A (el)
IS (1) IS2575B (el)
MA (1) MA27539A1 (el)
ME (1) ME00489B (el)
MX (1) MXPA05005437A (el)
NO (1) NO334247B1 (el)
NZ (1) NZ540659A (el)
PL (1) PL216752B1 (el)
PT (1) PT1567139E (el)
RS (1) RS51081B (el)
SI (1) SI1567139T1 (el)
TN (1) TNSN05131A1 (el)
UA (1) UA83018C2 (el)
WO (1) WO2004047829A1 (el)
ZA (1) ZA200503308B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
WO2006097456A1 (en) * 2005-03-16 2006-09-21 Nycomed Gmbh Taste masked dosage form containing roflumilast
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
UA98466C2 (uk) * 2006-07-05 2012-05-25 Нікомед Гмбх КОМБІНАЦІЯ ІНГІБІТОРА HMG-CоA-РЕДУКТАЗИ Й ІНГІБІТОРА ФОСФОДІЕСТЕРАЗИ 4, ПРИЗНАЧЕНА ДЛЯ ЛІКУВАННЯ ЗАПАЛЬНИХ ЗАХВОРЮВАНЬ ЛЕГЕНІВ
WO2013077830A1 (en) * 2011-11-25 2013-05-30 Mahmut Bilgic Synergistilly active combinations of roflumilast and carmoterol
US20130172303A1 (en) * 2012-01-03 2013-07-04 Forest Laboratories Holdings Ltd. Roflumilast compositions for the treatment of copd
SG11201505835QA (en) * 2013-01-28 2015-08-28 Incozen Therapeutics Pvt Ltd Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide
CN104800214A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入气雾剂复方及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
ES2176252T3 (es) * 1993-07-02 2002-12-01 Altana Pharma Ag Benzamidas sustituidas con fluoro-alcoxi y su utilizacion como agentes inhibidores de fosfodiesterasas de nucleotidos ciclicos.
IL130658A (en) * 1997-02-17 2004-07-25 Altana Pharma Ag Preparations for the treatment of ARDS or IRDS containing 3 - (cyclopropylmethoxy) - N - (3, 5 - dichloro - 4 - pyridinyl) - 4 - (difluoromethoxy) benzamide and solvent for the lungs
DE59814173D1 (de) * 1997-02-28 2008-04-03 Nycomed Gmbh Synergistische kombination von pde-hemmern und adenylatcyclase-agonisten bzw. guanylcyclyse-agonisten
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
IL141335A0 (en) * 1998-08-26 2002-03-10 Smithkline Beecham Corp Therapies for treating pulmonary diseases
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
EA006685B1 (ru) * 1999-08-21 2006-02-24 Алтана Фарма Аг Синергетическая композиция
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
ATE381537T1 (de) * 2001-03-22 2008-01-15 Glaxo Group Ltd Formanilid-derivative als beta2-adrenorezeptor- agonisten
SI1383786T1 (sl) * 2001-04-30 2009-02-28 Glaxo Group Ltd Protivnetni 17.beta-karbotioatestrski derivati androstana s ciklično estrsko skupino na položaju 17.alfa

Also Published As

Publication number Publication date
PL377732A1 (pl) 2006-02-06
DE60321953D1 (de) 2008-08-14
IL168308A (en) 2010-12-30
NO20052999L (no) 2005-06-17
US20060142308A1 (en) 2006-06-29
MXPA05005437A (es) 2005-08-03
TNSN05131A1 (en) 2007-05-14
CO5690570A2 (es) 2006-10-31
ATE399543T1 (de) 2008-07-15
MA27539A1 (fr) 2005-09-01
ES2309357T3 (es) 2008-12-16
DK1567139T3 (da) 2008-11-03
RS20050382A (en) 2007-08-03
ZA200503308B (en) 2006-11-29
RS51081B (sr) 2010-10-31
CA2506962A1 (en) 2004-06-10
IS7898A (is) 2005-06-20
WO2004047829A1 (en) 2004-06-10
PL216752B1 (pl) 2014-05-30
BR0316451A (pt) 2005-10-11
UA83018C2 (uk) 2008-06-10
EP1567139A1 (en) 2005-08-31
KR20050085104A (ko) 2005-08-29
NZ540659A (en) 2007-05-31
KR101071798B1 (ko) 2011-10-11
SI1567139T1 (sl) 2008-12-31
HK1081861A1 (en) 2006-05-26
HRP20050579A2 (hr) 2006-04-30
AU2003292120B2 (en) 2010-01-21
NO334247B1 (no) 2014-01-20
CN100346777C (zh) 2007-11-07
IS2575B (is) 2010-02-15
EA009935B1 (ru) 2008-04-28
JP2006508994A (ja) 2006-03-16
EP1567139B1 (en) 2008-07-02
HRP20050579B1 (hr) 2014-01-31
ME00489B (me) 2011-10-10
PT1567139E (pt) 2008-10-01
CN1713903A (zh) 2005-12-28
CA2506962C (en) 2012-01-03
AU2003292120A1 (en) 2004-06-18
WO2004047829A8 (en) 2005-06-30
EA200500774A1 (ru) 2005-12-29

Similar Documents

Publication Publication Date Title
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
DE60331236D1 (de) Orale zusammensetzungen zur behandlung von diabetes
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
NO20076405L (no) Anvendelse av 24-nor-UDCA
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη
SE0200657D0 (sv) Novel Formulation
NO20045343L (no) Ny kombinasjon for behandling av luftveisforstyrrelser
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
RS52038B (en) USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS